LPA and myeloid sarcoma: Notably, despite Lp(a) not being related to higher risk of MS as its concentration increased, individuals classified in the normal interval of  Lp(a) by reference values specific to our population [24] depicted a lower risk of developing MS when adjusted by other inflammatory factors.